• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Blood Grouping Reagents Market

    ID: MRFR/HC/51492-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Blood Grouping Reagents Market Research Report By Product (Consumables, Instruments), By Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), By Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, Antigen Typing) and By End User (Hospitals, Blood Banks, Clinical Laboratories)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Blood Grouping Reagents Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    UK Blood Grouping Reagents Market Summary

    The United Kingdom UK Blood Grouping Reagents market is poised for substantial growth over the next decade.

    Key Market Trends & Highlights

    UK Blood Grouping Reagents Key Trends and Highlights

    • The market valuation is projected to increase from 0.02 USD Million in 2024 to 0.13 USD Million by 2035.
    • A compound annual growth rate (CAGR) of 18.55% is anticipated from 2025 to 2035.
    • This growth trajectory suggests a rising demand for blood grouping reagents in the UK healthcare sector.
    • Growing adoption of advanced diagnostic technologies due to increasing awareness of blood safety is a major market driver.

    Market Size & Forecast

    2024 Market Size 0.02 (USD Million)
    2035 Market Size 0.13 (USD Million)
    CAGR (2025-2035) 18.55%

    Major Players

    PerkinElmer, Siemens Healthineers, Abbott Laboratories, C.B. Fleet Company, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Roche, Danaher Corporation, Genomic Health, Thermo Fisher Scientific, MilliporeSigma, Agilent Technologies, Grifols, F. Hoffmann-La Roche Ltd, Becton Dickinson

    UK Blood Grouping Reagents Market Trends

    The UK Blood Grouping Reagents Market is witnessing several significant trends, primarily driven by technological advancements and an increasing focus on patient safety. The rise in blood transfusion procedures and organ transplantation practices has led to a higher demand for accurate and reliable blood grouping reagents. This trend is further supported by the UK's commitment to improving healthcare outcomes and the efficient management of blood supplies, as highlighted by the National Health Service (NHS).

    Additionally, the push towards automation in testing processes is making blood grouping more efficient and reducing the likelihood of human error.As the blood-related disorders in the UK increase, there is potential to create innovative products that speed and enhance the accuracy of blood typing. In addition, the growing focus on personalized medicine provides opportunities to develop more specialized blood grouping reagents for different populations across diverse patients. Recently, there has been a tendency in the UK to incorporate digital technologies into the workflow of the laboratory.

    The use of laboratory information management systems (LIMS) and smart analyzers assists in better sample management in the laboratory and provides easy access to patient information. Fast access to patient information improves decision-making during emergencies.

    Sustainability efforts are also becoming prominent, as there is a noticeable shift towards eco-friendly production methods and packaging for reagents. Moreover, regulatory changes in the UK, particularly following Brexit, are shaping how blood grouping reagents are developed and brought to market. These developments are prompting stakeholders to ensure compliance and explore pathways that may enhance market entry for innovative products. Overall, the UK Blood Grouping Reagents Market presents a dynamic landscape of trends driven by technological advancements, regulatory shifts, and a heightened focus on patient-centered care.

    Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

    UK Blood Grouping Reagents Market Drivers

    Market Segment Insights

    Blood Grouping Reagents Market Product Insights

    Blood Grouping Reagents Market Product Insights

    The Product segment of the UK Blood Grouping Reagents Market is critical for ensuring precise blood typing and compatibility testing, an essential aspect of transfusion medicine and organ transplantation. The UK places a significant emphasis on patient safety and high-quality healthcare services, with blood grouping playing a pivotal role in these efforts. Within this segment, the market is further categorized into Consumables and Instruments, each playing a distinct yet interconnected role in the lifecycle of blood grouping procedures. Consumables are essential products such as reagents, test kits, and other supplies that are frequently utilized in laboratories and healthcare settings.

    These products are crucial as they ensure the availability of accurate and reliable results in a timely manner, aligning with the demands of fast-paced clinical environments and helping to maintain high standards of care. The reliance on consumables in blood testing indicates their dominance within the market, catering to hospitals, blood banks, and diagnostic laboratories across the UK. On the other hand, Instruments in blood grouping are equally vital, comprising advanced devices like hematology analyzers and blood typing machines.

    These instruments enhance operational efficiency through automation, thereby reducing human error and increasing throughput, which has become increasingly important as healthcare institutions strive to manage growing patient populations. The integration of innovative technologies within these instruments reflects a trend towards digitization in laboratory practices, aligning with broader initiatives in the UK healthcare system to leverage technology for improved patient outcomes. This emphasis on automating and streamlining processes not only supports the efficient functioning of medical facilities but also ensures compliance with rigorous regulatory standards, which is a key consideration for market participants aiming to operate in the UK.

    The ongoing evolution of both Consumables and Instruments, driven by technological advancements and increased awareness of the importance of accurate blood typing, continues to support robust growth in the UK Blood Grouping Reagents Market, paving the way for enhanced healthcare delivery and improved patient care.Overall, the Product segment remains integral to the standards established in transfusion and transplant medicine, indicating an essential area for investment and innovation within the UK Blood Grouping Reagents Market landscape.

    Blood Grouping Reagents Market Technique Insights

    Blood Grouping Reagents Market Technique Insights

    The UK Blood Grouping Reagents Market, particularly within the Technique segment, comprises various innovative methods that greatly enhance the accuracy and efficiency of blood group testing. Among these, PCR-based and Microarray Techniques are pivotal for their high sensitivity and specificity, enabling the detection of genetic variations crucial for transfusion compatibility and personalized medicine.

    Assay-Based Techniques are also noteworthy, as they provide rapid results, which are essential in emergency medical situations, thereby streamlining blood typing processes and ensuring patient safety.Massively Parallel Sequencing Techniques are transforming the field by allowing comprehensive genomic analyses, which can reveal complex blood group antigen profiles, facilitating better-informed transfusion decisions. Serology continues to be a cornerstone technique for blood grouping, leveraging antibodies to identify blood types effectively. This segment's growth is fueled by an increasing demand for blood transfusions, the rising prevalence of blood disorders, and advancements in technology that promote more rapid and reliable testing.

    As the UK healthcare system increasingly focuses on improving patient outcomes, the adoption of these advanced techniques in the Blood Grouping Reagents Market is expected to expand, highlighting their significance and relevance in today’s medical landscape.

    Blood Grouping Reagents Market Test Type Insights

    Blood Grouping Reagents Market Test Type Insights

    The Test Type segment of the UK Blood Grouping Reagents Market showcases a range of critical diagnostic tools essential for safe blood transfusions and organ transplants. Blood Group and Phenotypes testing serves as the foundation, ensuring compatibility between donors and recipients, thereby minimizing the risks of adverse reactions. Antibody Screening is also significant, as it helps detect unexpected antibodies, which can be crucial for patient safety. Crossmatching Tests play a vital role in validating blood types before transfusion, ensuring higher patient outcomes. Antibody Identification further augments the safety net by specifying any rare antibodies that may complicate transfusion procedures.

    Coombs’s Test is important for detecting antibodies bound to blood cells, while Antigen Typing identifies specific blood group antigens. Each of these tests contributes to the overall efficiency and safety of blood services in the UK, driven by a growing emphasis on patient safety and precision medicine. With the evolving healthcare landscape in the UK, the importance of these testing methods is likely to increase, leading to advancements in technologies and methodologies that support better blood transfusion practices.

    Blood Grouping Reagents Market End User Insights

    Blood Grouping Reagents Market End User Insights

    The End User segment of the UK Blood Grouping Reagents Market encompasses critical sectors such as Hospitals, Blood Banks, and Clinical Laboratories, each playing a vital role in the healthcare system. Hospitals are central to patient care, relying heavily on accurate blood grouping for safe transfusions and surgeries, making their need for reliable reagents crucial.

    Blood Banks focus on the collection and preservation of blood components, thus requiring high-quality reagents to ensure compatibility and efficiency in matching donors to recipients.Clinical Laboratories conduct a variety of analyses, providing essential data for diagnosing medical conditions, which necessitates the use of precise blood grouping reagents to ensure accurate results. As the demand for safe blood transfusions and the need for effective diagnostic tools continue to rise in the UK, the significance of this segment also grows, driven by advancements in technology and an increasing awareness of blood safety.

    Overall, this segment represents a fundamental aspect of healthcare delivery in the UK, where the emphasis on improving health outcomes is paramount.

    Get more detailed insights about UK Blood Grouping Reagents Market Research Report-Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The UK Blood Grouping Reagents Market is characterized by its dynamic nature, where various companies strive to establish their presence through innovative solutions and strategic positioning. The market is influenced by factors such as increasing demand for blood transfusions, advancements in biotechnology, and a heightened focus on patient safety. As hospitals and laboratories continually seek reliable and efficient reagents for blood grouping and typing, the competitive landscape is becoming increasingly fierce. Companies in this sector must navigate regulatory challenges while also adding value through product differentiation and technological advancements.

    Understanding the strengths and strategies of key players is critical for stakeholders looking to capitalize on growth opportunities within this specialized market.PerkinElmer has gained a competitive advantage in the UK Blood Grouping Reagents Market through its robust portfolio of high-quality reagents and diagnostic solutions tailored for clinical laboratories and hospitals. The company's focus on innovation is reflected in its development of advanced testing technologies that enhance the accuracy and efficiency of blood grouping processes. PerkinElmer's strength lies in its commitment to research and development, enabling it to introduce new products that meet the evolving needs of healthcare providers.

    Its strategic collaborations with healthcare institutions further bolster its position in the market, allowing for better dissemination of its offerings and enhanced visibility among potential customers. Additionally, the company’s established reputation and customer loyalty play a critical role in maintaining its foothold in this competitive sector.Siemens Healthineers is another prominent player in the UK Blood Grouping Reagents Market, known for its comprehensive range of diagnostic products and solutions designed to improve blood safety and patient outcomes. The company's key offerings include reagents, automation, and integrated systems that facilitate efficient blood grouping and typing processes.

    Siemens Healthineers benefits from its strong market presence achieved through strategic mergers and partnerships, allowing it to expand its reach and enhance its service offerings in the UK. The company’s strengths lie in its commitment to quality, innovation, and customer support, which have positioned it as a trusted brand within the healthcare sector. With a focus on leveraging technological advancements, Siemens Healthineers continues to develop next-generation solutions that address the growing demands of healthcare providers, thus reinforcing its competitive edge in the UK market for blood grouping reagents.

    Key Companies in the UK Blood Grouping Reagents Market market include

    Industry Developments

    Market Segmentation

    Outlook

    • Hospitals
    • Blood Banks
    • Clinical Laboratories

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 0.02(USD Million)
    MARKET SIZE 2024 0.02(USD Million)
    MARKET SIZE 2035 0.13(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 16.301% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED PerkinElmer, Siemens Healthineers, Abbott Laboratories, C.B. Fleet Company, BioRad Laboratories, Ortho Clinical Diagnostics, Roche, Danaher Corporation, Genomic Health, Thermo Fisher Scientific, MilliporeSigma, Agilent Technologies, Grifols, F. HoffmannLa Roche Ltd, Becton Dickinson
    SEGMENTS COVERED Product, Technique, Test Type, End User
    KEY MARKET OPPORTUNITIES Increased demand for transfusion safety, Technological advancements in blood testing, Growing incidence of blood disorders, Expansion of healthcare infrastructure, Rising awareness of personalized medicine.
    KEY MARKET DYNAMICS Increasing demand for blood transfusions, Advancements in reagent technology, Regulatory compliance and standards, Growth in diagnostic laboratories, Rising prevalence of blood disorders
    COUNTRIES COVERED UK

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the UK Blood Grouping Reagents Market in 2024?

    In 2024, the UK Blood Grouping Reagents Market is expected to be valued at approximately 0.02 USD Million.

    How much is the UK Blood Grouping Reagents Market projected to grow by 2035?

    By 2035, the market is projected to reach a value of around 0.13 USD Million.

    What is the compound annual growth rate (CAGR) for the UK Blood Grouping Reagents Market between 2025 and 2035?

    The market is expected to experience a CAGR of 16.301% during the forecast period from 2025 to 2035.

    Which products dominate the UK Blood Grouping Reagents Market?

    The market is divided into two main products: Consumables and Instruments.

    What will be the market value for Consumables in 2035?

    The market value for Consumables is anticipated to reach approximately 0.075 USD Million by 2035.

    What is the projected market value for Instruments by 2035?

    By 2035, the market for Instruments is expected to be valued at around 0.055 USD Million.

    Who are the major players in the UK Blood Grouping Reagents Market?

    Key players in the market include PerkinElmer, Siemens Healthineers, and Abbott Laboratories among others.

    What are the key growth drivers for the UK Blood Grouping Reagents Market?

    The growth of the market is driven by advancements in healthcare technology and an increasing demand for reliable blood grouping.

    What challenges does the UK Blood Grouping Reagents Market currently face?

    Challenges include high competition among key players and the need for continuous innovation in products.

    How does the UK Blood Grouping Reagents Market align with global market trends?

    The UK market aligns with global trends of increasing automation and digitization in healthcare, enhancing efficiency and accuracy.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. UK Blood Grouping Reagents Market, BY Product (USD Million)
    45. Consumables
    46. Instruments
    47. UK Blood Grouping Reagents Market, BY Technique (USD Million)
    48. PCR-based and Microarray Techniques
    49. Assay-Based Techniques
    50. Massively Parallel Sequencing Techniques
    51. Serology
    52. UK Blood Grouping Reagents Market, BY Test Type (USD Million)
    53. Blood Group and Phenotypes
    54. Antibody Screening
    55. Crossmatching Tests
    56. Antibody Identification
    57. Coombs’s Test
    58. Antigen Typing
    59. UK Blood Grouping Reagents Market, BY End User (USD Million)
    60. Hospitals
    61. Blood Banks
    62. Clinical Laboratories
    63. Competitive Landscape
    64. Overview
    65. Competitive Analysis
    66. Market share Analysis
    67. Major Growth Strategy in the Blood Grouping Reagents Market
    68. Competitive Benchmarking
    69. Leading Players in Terms of Number of Developments in the Blood Grouping Reagents Market
    70. Key developments and growth strategies
    71. New Product Launch/Service Deployment
    72. Merger & Acquisitions
    73. Joint Ventures
    74. Major Players Financial Matrix
    75. Sales and Operating Income
    76. Major Players R&D Expenditure. 2023
    77. Company Profiles
    78. PerkinElmer
    79. Financial Overview
    80. Products Offered
    81. Key Developments
    82. SWOT Analysis
    83. Key Strategies
    84. Siemens Healthineers
    85. Financial Overview
    86. Products Offered
    87. Key Developments
    88. SWOT Analysis
    89. Key Strategies
    90. Abbott Laboratories
    91. Financial Overview
    92. Products Offered
    93. Key Developments
    94. SWOT Analysis
    95. Key Strategies
    96. C.B. Fleet Company
    97. Financial Overview
    98. Products Offered
    99. Key Developments
    100. SWOT Analysis
    101. Key Strategies
    102. BioRad Laboratories
    103. Financial Overview
    104. Products Offered
    105. Key Developments
    106. SWOT Analysis
    107. Key Strategies
    108. Ortho Clinical Diagnostics
    109. Financial Overview
    110. Products Offered
    111. Key Developments
    112. SWOT Analysis
    113. Key Strategies
    114. Roche
    115. Financial Overview
    116. Products Offered
    117. Key Developments
    118. SWOT Analysis
    119. Key Strategies
    120. Danaher Corporation
    121. Financial Overview
    122. Products Offered
    123. Key Developments
    124. SWOT Analysis
    125. Key Strategies
    126. Genomic Health
    127. Financial Overview
    128. Products Offered
    129. Key Developments
    130. SWOT Analysis
    131. Key Strategies
    132. Thermo Fisher Scientific
    133. Financial Overview
    134. Products Offered
    135. Key Developments
    136. SWOT Analysis
    137. Key Strategies
    138. MilliporeSigma
    139. Financial Overview
    140. Products Offered
    141. Key Developments
    142. SWOT Analysis
    143. Key Strategies
    144. Agilent Technologies
    145. Financial Overview
    146. Products Offered
    147. Key Developments
    148. SWOT Analysis
    149. Key Strategies
    150. Grifols
    151. Financial Overview
    152. Products Offered
    153. Key Developments
    154. SWOT Analysis
    155. Key Strategies
    156. F. HoffmannLa Roche Ltd
    157. Financial Overview
    158. Products Offered
    159. Key Developments
    160. SWOT Analysis
    161. Key Strategies
    162. Becton Dickinson
    163. Financial Overview
    164. Products Offered
    165. Key Developments
    166. SWOT Analysis
    167. Key Strategies
    168. References
    169. Related Reports
    170. UK Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY PRODUCT, 2019-2035 (USD Billions)
    171. UK Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY TECHNIQUE, 2019-2035 (USD Billions)
    172. UK Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY TEST TYPE, 2019-2035 (USD Billions)
    173. UK Blood Grouping Reagents Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    174. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    175. ACQUISITION/PARTNERSHIP
    176. MARKET SYNOPSIS
    177. UK BLOOD GROUPING REAGENTS MARKET ANALYSIS BY PRODUCT
    178. UK BLOOD GROUPING REAGENTS MARKET ANALYSIS BY TECHNIQUE
    179. UK BLOOD GROUPING REAGENTS MARKET ANALYSIS BY TEST TYPE
    180. UK BLOOD GROUPING REAGENTS MARKET ANALYSIS BY END USER
    181. KEY BUYING CRITERIA OF BLOOD GROUPING REAGENTS MARKET
    182. RESEARCH PROCESS OF MRFR
    183. DRO ANALYSIS OF BLOOD GROUPING REAGENTS MARKET
    184. DRIVERS IMPACT ANALYSIS: BLOOD GROUPING REAGENTS MARKET
    185. RESTRAINTS IMPACT ANALYSIS: BLOOD GROUPING REAGENTS MARKET
    186. SUPPLY / VALUE CHAIN: BLOOD GROUPING REAGENTS MARKET
    187. BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2025 (% SHARE)
    188. BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2019 TO 2035 (USD Billions)
    189. BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2025 (% SHARE)
    190. BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2019 TO 2035 (USD Billions)
    191. BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2025 (% SHARE)
    192. BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2019 TO 2035 (USD Billions)
    193. BLOOD GROUPING REAGENTS MARKET, BY END USER, 2025 (% SHARE)
    194. BLOOD GROUPING REAGENTS MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    195. BENCHMARKING OF MAJOR COMPETITORS

    UK Blood Grouping Reagents Market Segmentation

    • Blood Grouping Reagents Market By Product (USD Million, 2019-2035)

      • Consumables
      • Instruments

     

    • Blood Grouping Reagents Market By Technique (USD Million, 2019-2035)

      • PCR-based and Microarray Techniques
      • Assay-Based Techniques
      • Massively Parallel Sequencing Techniques
      • Serology

     

    • Blood Grouping Reagents Market By Test Type (USD Million, 2019-2035)

      • Blood Group and Phenotypes
      • Antibody Screening
      • Crossmatching Tests
      • Antibody Identification
      • Coombs’s Test
      • Antigen Typing

     

    • Blood Grouping Reagents Market By End User (USD Million, 2019-2035)

      • Hospitals
      • Blood Banks
      • Clinical Laboratories

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027